Antiretroviral therapy coverage for PMTCT in Angola

Angola: Antiretroviral therapy coverage for PMTCT was 79.0% in 2024. ◆ Volatile

Latest (2024)
79.0%
Change on year
up 3.9%
World rank
43rd
of 84 countries
All-time high
79.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Angola, 2000–2024

0204060802000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 0 % of pregnant women living with HIV2004: 1 % of pregnant women living with HIV2005: 2 % of pregnant women living with HIV2006: 9 % of pregnant women living with HIV2007: 9 % of pregnant women living with HIV2008: 11 % of pregnant women living with HIV2009: 13 % of pregnant women living with HIV2010: 14 % of pregnant women living with HIV2011: 10 % of pregnant women living with HIV2012: 12 % of pregnant women living with HIV2013: 20 % of pregnant women living with HIV2014: 31 % of pregnant women living with HIV2015: 29 % of pregnant women living with HIV2016: 26 % of pregnant women living with HIV2017: 24 % of pregnant women living with HIV2018: 33 % of pregnant women living with HIV2019: 51 % of pregnant women living with HIV2020: 57 % of pregnant women living with HIV2021: 63 % of pregnant women living with HIV2022: 70 % of pregnant women living with HIV2023: 76 % of pregnant women living with HIV2024: 79 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage for pmtct in Angola is 79.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 3.9% on the previous year and up 154.8% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Angola peaked at 79.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Angola 43rd out of 84 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Angola, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Angola, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 1.0%
2005 2.0% +100.0%
2006 9.0% +350.0%
2007 9.0% +0.0%
2008 11.0% +22.2%
2009 13.0% +18.2%
2010 14.0% +7.7%
2011 10.0% -28.6%
2012 12.0% +20.0%
2013 20.0% +66.7%
2014 31.0% +55.0%
2015 29.0% -6.5%
2016 26.0% -10.3%
2017 24.0% -7.7%
2018 33.0% +37.5%
2019 51.0% +54.5%
2020 57.0% +11.8%
2021 63.0% +10.5%
2022 70.0% +11.1%
2023 76.0% +8.6%
2024 79.0% +3.9%

Angola compared with similar countries

  • Angola's 79.0% is below the median for lower middle income countries, which is 83.5%, 95% of the median. (32 countries reporting)
  • Angola's 79.0% is below the median for Sub-Saharan Africa, which is 82.0%, 96% of the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Angola changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2006 +350.0% 2.0% 9.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 4.5% 0.0% 13.0% 10
2010s 25.0% 10.0% 51.0% 10
2020s 69.0% 57.0% 79.0% 5

Countries ranked near Angola

  1. 40 South Sudan 81.0% compare
  2. 41 Cape Verde 80.0% compare
  3. 41 Guinea 80.0% compare
  4. 43 Guinea-Bissau 79.0% compare
  5. 43 Moldova 79.0% compare
  6. 46 Chad 77.0% compare
  7. 46 Gambia 77.0% compare

See the full ranking of 99 places →

More health data for Angola

All data for Angola →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Angola?
Antiretroviral therapy coverage for pmtct in Angola was 79.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Angola?
The highest recorded value was 79.0% in 2024.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Angola?
The lowest recorded value was 0.0% in 2000.
How does Angola rank for antiretroviral therapy coverage for pmtct?
Angola ranks 43rd out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Angola?
Over the last ten years it is up 154.8%. The long-run trend across the full record is volatile.
Where does this Angola data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Angola. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 17 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/angola/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/angola/">Antiretroviral therapy coverage for PMTCT in Angola</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).